MYC and cancer: Although the traditional approach to cancer targeted therapy focused on inhibiting the driver oncogene, pharmacological forcing of irremediable oncogenic stress has been suggested as a viable alternative, especially in the cancers where oncogene-targeted therapy is not feasible (e.g. MYC-driven cancers) or where tumors have gained resistance to the oncogene-targeting agent [8–11].